TRAVERE THERAPEUTICS INC
CUSIP 761299AB2
Travere Therapeutics Inc has 6 institutional holders in Filings Flow’s 13F database, together reporting 59.31M shares worth $55M as of Q4 2022. The largest reported holders are Braidwell LP, Css LLC/Il, and Indaba Capital Management, L.P..
Institutional Holders
6
Q4 2022
Reported Value
$55M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| BRAIDWELL LP$3.0B AUM | 1.52% | $54M | 56.03M | Q3 2024OLDER |
| CSS LLC/IL$2.1B AUM | 0.97% | $21M | 21.11M | Q2 2025 |
| DeepCurrents Investment Group LLC$3.1B AUM | 0.38% | $11M | 11.62M | Q2 2025 |
| Context Capital Management, LLC$4.3B AUM | 0.27% | $8M | 8.0K | Q2 2025 |
| OAKTREE CAPITAL MANAGEMENT LP$6.6B AUM | 0.02% | $1M | 1.38M | Q2 2025 |
| LAZARD ASSET MANAGEMENT LLC$60.8B AUM | 0.01% | $9,329 | 9.46M | Q2 2025 |
| Russell Investments Group, Ltd.$93.1B AUM | 0.00% | $1M | 1.04M | Q2 2025 |
| Jefferies Financial Group Inc.$14.6B AUM | 0.00% | $29,655 | 30.0K | Q2 2025 |
| DEUTSCHE BANK AG\$302.7B AUM | 0.00% | $28,515 | 30.0K | Q3 2024OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.